Open AccessRetinal Vasculitis Secondary to Durvalumab
Author(s) -
R. Andrade Antonio,
Moll-Udina Aina,
Martin Ruth,
Cilveti Esther,
Subirà Olaia,
Disfetano Laura,
García-Arumí Jose
Publication year - 2020
Publication title -
case reports in ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.299
H-Index - 17
ISSN - 1663-2699
DOI - 10.1159/000507609
Subject(s) - case report
Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, the retinal vasculitis resolved and macular edema improved during follow-up. There was no need for durvalumab to be withdrawn.